Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Study Expands Bone Biology Knowledge

May 9, 2011 8:50 am | News | Comments

Acceleron Pharma, Inc. announced preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.

TOPICS:

Capturing More in Microscopy Images

May 9, 2011 8:49 am | by Mike May, PhD, Contributing Editor | Articles | Comments

Advanced microscopic cameras use sophisticated sensors to capture images. New developments in sensors are bringing more features into view.

TOPICS:

Using Bead-Based Multiplexing Immunoassays to Explore Cellular Response to Drugs

May 9, 2011 8:36 am | by Brett Houser, Bio-Plex Product Manager; Bio-Rad Laboratories,Hercules, Calif. | Articles | Comments

Multiplex bead-based immunoassays, such as Luminex xMAP technology, allow the simultaneous measurement of multiple analytes using a library of antibodies coupled to color-coded beads.

TOPICS:
Advertisement

Spectroscopic Data System

May 9, 2011 8:30 am | Product Releases | Comments

Symbion Systems, Inc. released the Symbion-DX, Version 2.5, which includes expanded database functionality, instrument control, spectroscopic data processing, and methods development capabilities.

TOPICS:

Increasing Immunoassay Specificity with Novel Plate Formats

May 9, 2011 8:30 am | by Thomas Andersen, MSc, Sr. Technical Adviser; Thermo Fisher Scientific, Roskilde, Denmark | Articles | Comments

Immunoassays are based on the ability of an antibody to bind with high specificity to a specific antigen molecule, producing a measurable signal that can be used to determine quantitative information of the antigen concentration.

TOPICS:

Multiplex Chemiluminescent ELISA for the Detection of Interferons and Related Cytokines

May 9, 2011 8:23 am | by Thomas. B. Lavoie, PhD, Director of Product Development; William Clark, PhD, Vice President of Science and Strategic Alliance; Yognandan Pandya, Quality Manager; PBL InterferonSource, Piscataway, NJ | Articles | Comments

Multiplex technology has become a powerful tool for examining analytes in a variety of biological samples. The advantages of this approach include time, sample, and cost savings relative to singleplex analysis of samples.

TOPICS:

Researchers Find Temperature-Sensing Protein

May 9, 2011 8:11 am | News | Comments

Researchers at The Scripps Research Institute found a temperature-sensing protein that allows calcium to pour in and activate an immune response when tripped.

TOPICS:

Data Delivery of INDs

May 9, 2011 8:11 am | by Scott Weiss, PhD, Director of Product Strategy; ID Business Solutions Ltd, Bridgewater, N.J. | Articles | Comments

At a time of unprecedented change within the pharmaceutical industry, improved insight into the process and the efficient progression of preclinical discoveries into clinical development projects is critical.

TOPICS:
Advertisement

Zombie Ants Have Fungus on Brain

May 9, 2011 8:08 am | News | Comments

New research revealed how infection by a parasitic fungus dramatically changes the behavior of tropical of carpenter ants, causing them to become zombie-like and to die...

TOPICS:

Biomarker Researchers Seek Qualified Successes

May 9, 2011 7:36 am | by Alan Dove, Contributing Editor | Articles | Comments

The barriers between the biomarker lab and the clinic are manifold, but validation and qualification are clearly the biggest. New guidelines, tools, and techniques are helping scientists mine a mountain of potential biomarkers for a few precious gems.

TOPICS:

J & J Files New Concerta Lawsuit Against Impax Labs

May 9, 2011 5:49 am | News | Comments

Impax Laboratories Inc. received a second patent lawsuit from Johnson & Johnson's Alza Corp. division related to Impax's proposed generic version of drug Concerta, which treats the attention deficit hyperactivity disorder.

TOPICS:

Alkermes, Elan Drug Technologies to Merge

May 9, 2011 5:45 am | News | Comments

Alkermes, Inc and Elan Corporation announced the execution of a definitive agreement under which Alkermes will merge with Elan Drug Technologies (EDT), in a cash and stock transaction currently valued at approximately $960 million.

TOPICS:

French Drugmaker Shortens Name to Sanofi

May 9, 2011 5:34 am | News | Comments

French drugmaker Sanofi-Aventis SA shortened its name to Sanofi, a move approved by shareholders at the company's annual meeting in Paris.

TOPICS:

The Heart of Dosing Safety

May 6, 2011 1:11 pm | by Alan Copa, PharmD, President, Cetero Research, Fargo, N.D. | Articles | Comments

Over the last decade, cardiac safety concerns have become the leading reason that drugs are pulled from the market. As a result, thorough QT studies are more important than ever.

TOPICS:

The Softer Side of Genomics

May 6, 2011 12:44 pm | by Mike May, PhD; Contributing Editor | Articles | Comments

Today’s data-management and computational tools let researchers dig deeper into genes.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading